HOUSTON/PRNewswire/ — Houston Medical Robotics, Inc.
announces that it has received U.S. Food and Drug Administration 510(k)
clearance to market the Euclid™ Tier 1 Mini Access System. The Euclid™ Tier 1
Mini Access System is a portable, hand-held device that integrates commercially
available ultrasound imaging systems to facilitate placement of a needle and
guidewire into a targeted anatomical location for a variety of therapeutics
applications.
“Although numerous applications have been identified,
our initial target for the Euclid™ Tier 1 Mini Access System is reducing
complications associated with central venous catheter (CVC) placement,”
stated Jeffery J. Sheldon, Houston Medical Robotics, Inc. Chairman & CEO. “With
over 5 million CVCs placed each year – and published complication rates are as
high as 26% – we are poised to make a significant impact on healthcare
outcomes,” stated Mr. Sheldon.
Technology limitations, inadequate procedure training &
exposure, and varying patient size & morphology have all been identified as
co-contributors to the high CVC placement complication rates. Use of ultrasound
imaging during procedures has been shown to reduce complications; however, the
procedure is cumbersome and generally requires additional assistance. “The
Euclid™ Tier 1 Mini Access System places all the necessary tools and
consumables readily at hand for single-operator safe, effective, rapid, and
cost-effective access,” stated Mr. Sheldon.
About Houston Medical Robotics, Inc.
Houston Medical Robotics, Inc. develops & commercializes revolutionary
image guided hand-held medical robotics for use in various therapeutic
applications. The devices provide safer, cheaper, and more effective procedure
alternatives, thereby increasing caregiver efficiency, hospital & clinic
revenue, and overall patient satisfaction. Houston Medical Robotics, Inc.
raised $2.2 million from CitareTx Investment Partners I, LP, a Texas based medical
device investment fund and business incubator, also founded and managed by Mr.
Sheldon.
